These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 26759373

  • 1. The Relationship Between Lymphocyte-to-Monocyte Ratio and Bare-Metal Stent In-Stent Restenosis in Patients With Stable Coronary Artery Disease.
    Murat SN, Yarlioglues M, Celik IE, Kurtul A, Duran M, Kilic A, Oksuz F.
    Clin Appl Thromb Hemost; 2017 Apr; 23(3):235-240. PubMed ID: 26759373
    [Abstract] [Full Text] [Related]

  • 2. A potential marker of bare metal stent restenosis: monocyte count - to- HDL cholesterol ratio.
    Ucar FM.
    BMC Cardiovasc Disord; 2016 Oct 03; 16(1):186. PubMed ID: 27716070
    [Abstract] [Full Text] [Related]

  • 3. The association of red cell distribution width with in-stent restenosis in patients with stable coronary artery disease.
    Kurtul A, Murat SN, Yarlioglues M, Duran M, Karadeniz M, Ergun G, Akyel A, Mendi MA, Oksuz F.
    Platelets; 2015 Oct 03; 26(1):48-52. PubMed ID: 24831828
    [Abstract] [Full Text] [Related]

  • 4. Role of red blood cell distribution in predicting drug-eluting stent restenosis in patients with stable angina pectoris after coronary stenting.
    Zhao K, Li YJ, Gao S.
    Coron Artery Dis; 2015 May 03; 26(3):220-4. PubMed ID: 25647458
    [Abstract] [Full Text] [Related]

  • 5. Usefulness of the neutrophil-to-lymphocyte ratio to predict bare-metal stent restenosis.
    Turak O, Ozcan F, Isleyen A, Tok D, Sokmen E, Buyukkaya E, Aydogdu S, Akpek M, Kaya MG.
    Am J Cardiol; 2012 Nov 15; 110(10):1405-10. PubMed ID: 22858185
    [Abstract] [Full Text] [Related]

  • 6. Preprocedural Albumin Levels and Risk of In-Stent Restenosis After Coronary Stenting With Bare-Metal Stent.
    Celik IE, Yarlioglues M, Kurtul A, Duran M, Koseoglu C, Oksuz F, Aksoy O, Murat SN.
    Angiology; 2016 May 15; 67(5):478-83. PubMed ID: 26243483
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Usefulness of the platelet-to-lymphocyte ratio in predicting bare-metal stent restenosis.
    Yılmaz S, Sen F, Ünal S, Yayla C, Özeke Ö, Aras D, Topaloglu S, Aydogdu S.
    Scand Cardiovasc J; 2015 Feb 15; 49(1):39-44. PubMed ID: 25414124
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Acute coronary syndrome - a frequent clinical manifestation of bare metal in-stent restenosis.
    Drozd J, Wójcik J, Małek R, Korona B, Zapolski T, Wysokiński A.
    Kardiol Pol; 2010 Jun 15; 68(6):637-45. PubMed ID: 20806192
    [Abstract] [Full Text] [Related]

  • 12. Usefulness of preprocedural serum uric acid level to predict restenosis of bare metal stents.
    Turak O, Canpolat U, Özcan F, Mendi MA, Oksüz F, Işleyen A, Gürel OM, Çay S, Aras D, Aydoğdu S.
    Am J Cardiol; 2014 Jan 15; 113(2):197-202. PubMed ID: 24157191
    [Abstract] [Full Text] [Related]

  • 13. Association between VEGF Gene Polymorphisms and In-Stent Restenosis after Coronary Intervention Treated with Bare Metal Stent.
    Bagyura Z, Kiss L, Hirschberg K, Berta B, Széplaki G, Lux Á, Szelid Z, Soós P, Merkely B.
    Dis Markers; 2017 Jan 15; 2017():9548612. PubMed ID: 28484288
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Influence of insulin resistance on in-stent restenosis in patients undergoing coronary drug-eluting stent implantation after long-term angiographic follow-up.
    Zhao LP, Xu WT, Wang L, Li H, Shao CL, Gu HB, Chan SP, Xu HF, Yang XJ.
    Coron Artery Dis; 2015 Jan 15; 26(1):5-10. PubMed ID: 25211654
    [Abstract] [Full Text] [Related]

  • 16. Effectiveness of everolimus-eluting stents in the treatment of drug-eluting stent versus bare-metal stent restenosis.
    Almalla M, Pross V, Marx N, Hoffmann R.
    Coron Artery Dis; 2012 Nov 15; 23(7):492-6. PubMed ID: 22990414
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.